Rapid Micro Biosystems, Inc. RPID
1.11
0.00
0.00%
as of 25 Sep
- Market cap
- $55.7M
- P/E
- 0.0×
Follow RPID
Growth Flags
show if company had growth for consecutive years
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 0.69 | 0.69 | 9.06 | 3.02 | 1.74 | 1.40 | 3.86 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | (1.29) | (1.29) | (16.33) | (4.44) | (4.12) | (3.96) | (39.92) |
P/B ratio |
— | 0.00 | 0.00 | 0.95 | 0.32 | 0.33 | 0.52 | 3.90 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.96 | 0.32 | 0.33 | 0.53 | 4.00 |
EV/Sales |
— | (2.79) | (2.79) | 0.75 | (2.90) | (2.06) | (0.18) | 3.28 |
EV/EBITDA |
— | 1.65 | 1.65 | 0.00 | 0.82 | 0.87 | 0.11 | 0.00 |
EV/Operating CF |
— | 1.64 | 1.64 | (0.32) | 0.85 | 1.03 | 0.11 | (3.55) |
EV/FCF |
— | 1.59 | 1.59 | (0.30) | 0.76 | 0.99 | 0.11 | (3.45) |
Quick Ratio |
— | 1.53 | 3.22 | 10.93 | 5.99 | 5.14 | 3.32 | 2.24 |
Current Ratio |
— | 2.24 | 4.00 | 12.01 | 7.27 | 6.34 | 4.61 | 3.31 |
Net Debt/EBITDA |
— | (0.31) | 0.70 | 4.23 | 1.68 | 1.72 | 1.09 | 0.44 |
Debt/Assets |
0.00% | 56.19% | 35.44% | 0.17% | 3.78% | 0.00% | 0.00% | 25.25% |
Debt/Equity |
— | (0.22) | (0.20) | 0.00 | 0.04 | 0.00 | 0.00 | 0.57 |
Asset Turnover |
— | 1.04 | 0.32 | 0.15 | 0.08 | 0.13 | 0.23 | 0.39 |
Operating CF/Net income |
— | 0.79 | 0.69 | 0.70 | 0.96 | 0.86 | 0.94 | 0.66 |
Capex/Depreciation |
— | (1.16) | (0.46) | (2.09) | (2.38) | (0.59) | (0.41) | (0.26) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 25.40% | 43.15% | (166.07%) | (31.58%) | (37.19%) | (48.50%) | (86.82%) | |
| — | (168.01%) | (88.94%) | (50.15%) | (28.16%) | (31.41%) | (38.81%) | (54.47%) | |
ROIC |
— | 0.00% | 0.00% | (105.87%) | (62.99%) | (136.30%) | (126.72%) | (214.45%) |
Return on Tangible Assets |
— | (128.75%) | (84.28%) | (36.94%) | (45.60%) | (45.92%) | (62.90%) | (91.23%) |
Average Days of Receivables |
— | 80.18 | 113.24 | 78.63 | 114.38 | 89.67 | 97.84 | 34.06 |
Research and Development Expense of Revenue |
— | 32.88% | 40.62% | 42.10% | 75.09% | 56.93% | 52.04% | 40.50% |
Selling, General and Administrative Expense of Revenue |
— | 78.55% | 99.14% | 127.88% | 244.05% | 169.89% | 125.53% | 103.72% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 2.86% | 3.32% | 7.93% | 23.46% | 21.09% | 13.81% | 12.01% |
Graham Net Nets |
— | (11.82) | (11.82) | 0.94 | 2.16 | 2.43 | 1.48 | 0.15 |
Graham Number |
— | 0.00 | 906.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (508.88%) | (508.88%) | (522.08%) | (117.21%) | (134.07%) | (120.00%) | (36.90%) |
Free Cash Flow Yield |
— | (254.44%) | (254.44%) | (27.63%) | (126.05%) | (119.86%) | (116.06%) | (24.63%) |
Revenue per Share |
— | 47.72 | 44.78 | 1.17 | 0.40 | 0.52 | 0.64 | 0.75 |
Operating CF per Share |
— | (61.12) | (86.34) | (2.78) | (1.38) | (1.05) | (1.01) | (0.70) |
Capex per Share |
— | (4.90) | (1.92) | (0.16) | (0.16) | (0.04) | (0.03) | (0.02) |
Free Cash Flow per Share |
— | (66.02) | (88.26) | (2.94) | (1.54) | (1.09) | (1.04) | (0.71) |
Cash per Share |
— | 36.01 | 125.56 | 9.78 | 2.56 | 2.14 | 1.16 | 0.86 |
Shareholders Equity per Share |
— | (238.66) | (353.78) | 11.17 | 3.87 | 2.74 | 1.73 | 0.74 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (238.66) | (353.78) | 11.17 | 3.87 | 2.74 | 1.73 | 0.74 |
Free Cash Flow |
— | (22.84) | (31.69) | (58.16) | (65.29) | (46.93) | (45.52) | (31.91) |
Working Capital |
— | 13.08 | 46.61 | 199.96 | 119.53 | 101.43 | 63.35 | 42.68 |
Capital Expenditures |
— | (1.69) | (0.69) | (3.20) | (6.74) | (1.84) | (1.36) | (0.85) |
Net Current Asset Value |
— | (90.65) | (134.85) | 197.94 | 112.10 | 94.95 | 58.10 | 19.52 |
EV/EBIT |
— | 1.59 | 1.59 | 0.00 | 0.79 | 0.82 | 0.10 | 0.00 |
Capex to Sales |
— | 0.10 | 0.04 | 0.14 | 0.39 | 0.08 | 0.05 | 0.03 |
Net Profit Margin |
— | (161.22%) | (281.28%) | (335.88%) | (354.91%) | (232.99%) | (167.16%) | (140.30%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 0.19 | 0.21 | 0.14 | 0.21 | 0.24 | 0.30 | 0.36 |
Cash ROIC |
— | 54.94% | 66.61% | (15.97%) | (25.84%) | (27.57%) | (43.90%) | (44.28%) |
Accounts Receivable Turnover |
— | 3.34 | 3.73 | 4.65 | 3.30 | 4.13 | 4.30 | 6.31 |
Accounts Payable Turnover |
— | 4.36 | 6.29 | 7.36 | 5.48 | 7.57 | 12.49 | 9.75 |
Inventory Turnover |
— | 2.28 | 3.28 | 2.51 | 1.39 | 1.36 | 1.40 | 1.72 |
Average Days of Payables |
— | 69.99 | 67.53 | 46.48 | 77.17 | 25.72 | 32.86 | 46.43 |
Days of Inventory on Hand |
— | 125.37 | 135.51 | 184.67 | 301.22 | 260.17 | 261.83 | 197.34 |
Average Receivables |
— | 4.95 | 4.31 | 5.00 | 5.19 | 5.45 | 6.53 | 5.33 |
Average Payables |
— | 3.84 | 3.84 | 4.21 | 4.69 | 3.70 | 2.25 | 3.34 |
Average Inventory |
— | 7.36 | 7.36 | 12.32 | 18.43 | 20.57 | 20.08 | 18.90 |
Average Assets |
— | 15.84 | 50.84 | 155.58 | 215.91 | 167.05 | 120.81 | 86.51 |
Average Common Equity |
— | (104.79) | (104.79) | 46.99 | 192.57 | 141.08 | 96.67 | 54.28 |
Columns are period end dates